Alexander Westermann

Alexander Westermann


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ASAntoine-Emmanuel Saliba
Antoine-Emmanuel Saliba
AWAlexander Westermann
Alexander Westermann
SGStanislaw A. Gorski
Stanislaw A. Gorski
JVJörg Vogel
Jörg Vogel
Phenotypically identical cells can dramatically vary with respect to behavior during their lifespan and this variation is reflected in their molecular composition such as the transcriptomic landscape. Single-cell transcriptomics using next-generation transcript sequencing (RNA-seq) is now emerging as a powerful tool to profile cell-to-cell variability on a genomic scale. Its application has already greatly impacted our conceptual understanding of diverse biological processes with broad implications for both basic and clinical research. Different single-cell RNA-seq protocols have been introduced and are reviewed here—each one with its own strengths and current limitations. We further provide an overview of the biological questions single-cell RNA-seq has been used to address, the major findings obtained from such studies, and current challenges and expected future developments in this booming field.

14 August 2012 in Nature Reviews Microbiology
Verified
Journal Article
Open access
AWAlexander Westermann
Alexander Westermann
SGStanislaw A. Gorski
Stanislaw A. Gorski
JVJörg Vogel
Jörg Vogel
A comprehensive understanding of host-pathogen interactions requires a knowledge of the associated gene expression changes in both the pathogen and the host. Traditional, probe-dependent approaches using microarrays or reverse transcription PCR typically require the pathogen and host cells to be physically separated before gene expression analysis. However, the development of the probe-independent RNA sequencing (RNA-seq) approach has begun to revolutionize transcriptomics. Here, we assess the feasibility of taking transcriptomics one step further by performing 'dual RNA-seq', in which gene expression changes in both the pathogen and the host are analysed simultaneously.

7 December 2018 in Science
Verified
Journal Article
Open access
PDF file
DSDaphne A. C. Stapels
Daphne A. C. Stapels
PHPeter W. S. Hill
Peter W. S. Hill
AWAlexander Westermann
Alexander Westermann
RFRobert A. Fisher
Robert A. Fisher
TTTeresa L. Thurston
Teresa L. Thurston
SHSophie Helaine
Sophie Helaine
Actively persistent Salmonella: A proportion of Salmonella cells can enter a reversible state of growth arrest, which allows them to tolerate environmental stress such as antibiotics. Stapels et al. found that these cells are not dormant but are actively modulating their environment. Salmonella within their host macrophage niche deployed a specialized type 3 secretory system called SPI-2 to deliver virulence factors, including SteE, into host cells. SteE changed the cytokine profile of the infected macrophages to reprogram them into a noninflammatory and infection-permissive state. Thus, when antibiotics were removed, the Salmonella could reemerge and cause disease. Science , this issue p. 1156

7 November 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
LSLeon Schulte
Leon Schulte
AWAlexander Westermann
Alexander Westermann
JVJörg Vogel
Jörg Vogel
Many microRNAs (miRNAs) are co-regulated during the same physiological process but the underlying cellular logic is often little understood. The conserved, immunomodulatory miRNAs miR-146 and miR-155, for instance, are co-induced in many cell types in response to microbial lipopolysaccharide (LPS) to feedback-repress LPS signalling through Toll-like receptor TLR4. Here, we report that these seemingly co-induced regulatory RNAs dramatically differ in their induction behaviour under various stimuli strengths and act non-redundantly through functional specialization; although miR-146 expression saturates at sub-inflammatory doses of LPS that do not trigger the messengers of inflammation markers, miR-155 remains tightly associated with the pro-inflammatory transcriptional programmes. Consequently, we found that both miRNAs control distinct mRNA target profiles; although miR-146 targets the messengers of LPS signal transduction components and thus downregulates cellular LPS sensitivity, miR-155 targets the mRNAs of genes pervasively involved in pro-inflammatory transcriptional programmes. Thus, miR-155 acts as a broad limiter of pro-inflammatory gene expression once the miR-146 dependent barrier to LPS triggered inflammation has been breached. Importantly, we also report alternative miR-155 activation by the sensing of bacterial peptidoglycan through cytoplasmic NOD-like receptor, NOD2. We predict that dose-dependent responses to environmental stimuli may involve functional specialization of seemingly co-induced miRNAs in other cellular circuitries as well.

17 February 2021 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
AWAlexander Westermann
Alexander Westermann
JVJörg Vogel
Jörg Vogel

21 July 2022 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
ESEv-Marie Schuster
Ev-Marie Schuster
MEMaximilian W. Epple
Maximilian W. Epple
KGKatharina M. Glaser
Katharina M. Glaser
MMMichael Mihlan
Michael Mihlan
KLKerstin Lucht
Kerstin Lucht
ARAngelika S. Rambold
Angelika S. Rambold
Successful elimination of bacteria in phagocytes occurs in the phago-lysosomal system, but also depends on mitochondrial pathways. Yet, how these two organelle systems communicate is largely unknown. Here we identify the lysosomal biogenesis factor transcription factor EB (TFEB) as regulator for phago-lysosome-mitochondria crosstalk in macrophages. By combining cellular imaging and metabolic profiling, we find that TFEB activation, in response to bacterial stimuli, promotes the transcription of aconitate decarboxylase (Acod1, Irg1) and synthesis of its product itaconate, a mitochondrial metabolite with antimicrobial activity. Activation of the TFEB–Irg1–itaconate signalling axis reduces the survival of the intravacuolar pathogen Salmonella enterica serovar Typhimurium. TFEB-driven itaconate is subsequently transferred via the Irg1-Rab32–BLOC3 system into the Salmonella-containing vacuole, thereby exposing the pathogen to elevated itaconate levels. By activating itaconate production, TFEB selectively restricts proliferating Salmonella, a bacterial subpopulation that normally escapes macrophage control, which contrasts TFEB’s role in autophagy-mediated pathogen degradation. Together, our data define a TFEB-driven metabolic pathway between phago-lysosomes and mitochondria that restrains Salmonella Typhimurium burden in macrophages in vitro and in vivo.